 | |
| Clinical data | |
|---|---|
| ATC code |
|
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C12H17NO |
| Molar mass | 191.274 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
 N Y (what is this?) (verify) | |
3,4-Dimethylmethcathinone (3,4-DMMC) is astimulant drug first reported in 2010 as adesigner drug analogue ofmephedrone, apparently produced in response to the banning of mephedrone, following its widespread abuse in many countries in Europe and around the world.[1] 3,4-DMMC has been seized as a designer drug inAustralia.[2]In vitro, 3,4-DMMC was shown to be amonoamine transporter substrate that potently inhibits norepinephrine and serotonin reuptake, and to a lesser extent dopamine reuptake.[3]
As of October 2015 3,4-DMMC is a controlled substance in China.[4]
3,4-DMMC is banned in the Czech Republic.[5]
In the United States 3,4-DMMC is considered aSchedule I controlled substance as a positional isomer of4-Methylethcathinone (4-MEC).[6]
